Literature DB >> 20713051

Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats.

Ramiro Gonzalez-Aparicio1, Juan A Flores, Emilio Fernandez-Espejo.   

Abstract

The objective was to analyze functional effects of the combination of GDNF and TGF-β1 in the retrograde model of Parkinsonism in rats, based on the intrastriatal infusion of 6-hydroxydopamine, which leads to protracted and progressive cell death in the substantia nigra. Hemiparkinsonian rats were implanted with osmotic minipumps 2 months after striatal lesion, pumps delivering GDNF alone (10 ng/day), TGF-β1 alone (2 ng/day), or a GDNF and TGF-β1 combination. The findings confirmed that GDNF alone has potent dopaminotrophic effects but they also revealed, for the first time, that GDNF and TGF-β1 co-infusion led to stronger trophic effects relative to the infusion of GDNF alone. TGF-β1 allowed further reducing dopamine receptor hypersensitivity, and potentiated GDNF-mediated effects. This cooperation could be accounted for by the recruitment of GFRα1 on striatal membranes, and by enhanced expression and activation of TH through augmented pSer31TH and pSer40TH. Co-infusion induced striatal sprouting, as revealed by augmentation of p21-Arc, stathmin, and synaptophysin, and led to a reliable recovery of phenotypic expression of TH in surviving nigral neurons. Functional recovery and improvement of TH signal in the nigrostriatal system were long-lasting and sustained, remaining after cessation of trophic infusion.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713051     DOI: 10.1016/j.expneurol.2010.08.016

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

Review 1.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

2.  Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF.

Authors:  Caroline Gouarné; Marc Giraudon-Paoli; Mathieu Seimandi; Clotilde Biscarrat; Gwenaëlle Tardif; Rebecca M Pruss; Thierry Bordet
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

3.  TGFβ1 treatment reduces hippocampal damage, spontaneous recurrent seizures, and learning memory deficits in pilocarpine-treated rats.

Authors:  Liang-Yong Li; Jia-Lin Li; Hui-Min Zhang; Wen-Ming Yang; Kai Wang; Yuan Fang; Yu Wang
Journal:  J Mol Neurosci       Date:  2012-08-31       Impact factor: 3.444

Review 4.  Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.

Authors:  Erin John Rieger de Almeida; Hélio Jungkenn Ibrahim; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Andréia Machado Cardoso
Journal:  Neurochem Res       Date:  2022-08-13       Impact factor: 4.414

5.  Neuronal and astroglial TGFβ-Smad3 signaling pathways differentially regulate dendrite growth and synaptogenesis.

Authors:  Chuan-Yong Yu; Wei Gui; Hui-Yan He; Xiao-Shan Wang; Jian Zuo; Lin Huang; Nong Zhou; Kai Wang; Yu Wang
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

6.  Enhanced efficacy of the CDNF/MANF family by combined intranigral overexpression in the 6-OHDA rat model of Parkinson's disease.

Authors:  Óscar Cordero-Llana; Benjamin C Houghton; Federica Rinaldi; Hannah Taylor; Rafael J Yáñez-Muñoz; James B Uney; Liang-Fong Wong; Maeve A Caldwell
Journal:  Mol Ther       Date:  2014-11-05       Impact factor: 11.454

7.  Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.

Authors:  Stefan Jean-Pierre Haas; Xiaolai Zhou; Venissa Machado; Andreas Wree; Kerstin Krieglstein; Björn Spittau
Journal:  Front Mol Neurosci       Date:  2016-02-03       Impact factor: 5.639

8.  Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.

Authors:  Merja H Voutilainen; Francesca De Lorenzo; Polina Stepanova; Susanne Bäck; Li-Ying Yu; Päivi Lindholm; Eeva Pörsti; Mart Saarma; Pekka T Männistö; Raimo K Tuominen
Journal:  eNeuro       Date:  2017-03-13

9.  Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.

Authors:  Rafael Gonzalo-Gobernado; Lucía Calatrava-Ferreras; Diana Reimers; Antonio Sánchez Herranz; Macarena Rodríguez-Serrano; Cristina Miranda; Adriano Jiménez-Escrig; Juan José Díaz-Gil; Eulalia Bazán
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

10.  TGF-β-Induced Phosphorylation of Usp9X Stabilizes Ankyrin-G and Regulates Dendritic Spine Development and Maintenance.

Authors:  Sehyoun Yoon; Euan Parnell; Peter Penzes
Journal:  Cell Rep       Date:  2020-05-26       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.